Delta-8-THCM
Pharmaceutical compound
From Wikipedia, the free encyclopedia
Delta-8-THCM (O-Methyl-Δ8-THC) is a chemical compound related to phytocannabinoids found in Cannabis. It has been sold as a designer drug, first identified in Sweden in June 2024.[1] However, it is a known compound which has been well established to almost entirely lack cannabinoid-like effects in mice, rats and monkeys,[2][3] unlike the dimethylheptyl analogue L-759,633 which is a selective agonist for CB2 and has antiinflammatory but not psychoactive effects.[4]
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C22H32O2 |
| Molar mass | 328.496 g·mol−1 |
| 3D model (JSmol) | |
| |
| |